The coronavirus disease 2019 (COVID-19) pandemic has affected persons suffering from substance use disorders (SUDs) all around the world. The purpose of this study was to investigate changes in the number of SUD treatment...
Dear friends and colleagues,
The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022.
Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good...
Ecolink Alumnis honor global trainers as outstanding Women of the Year on Women’s day.
Mangalore, India: Ecolink Alumni Association with over 200 students from 18 countries honored its Master trainers who trained over 250 addiction...
Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who initiate...
Background
Between 65-87% of patients in addiction treatment smoke tobacco, compared to about 21% of the general population. These high rates of tobacco use contribute to significant patient suffering and early death. Over 53% of people...
Substance use disorder (SUD) is common among victims of sex trafficking. Traffickers may exploit individuals' existing opioid use or other SUDs to coerce them into sex trafficking, or they may facilitate substance use to keep trafficking...
To determine whether participation in the United Nations Office on Drugs and Crime (UNODC) and the World Health Organization’s (WHO) Stop Overdose Safely (S-O-S) take-home naloxone training project in Kazakhstan...
